rs115466848

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001853.4(COL9A3):​c.792+19G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00202 in 1,612,204 control chromosomes in the GnomAD database, including 66 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 43 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 23 hom. )

Consequence

COL9A3
NM_001853.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.356

Publications

2 publications found
Variant links:
Genes affected
COL9A3 (HGNC:2219): (collagen type IX alpha 3 chain) This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. Mutations in this gene are associated with multiple epiphyseal dysplasia type 3. [provided by RefSeq, Jan 2010]
COL9A3 Gene-Disease associations (from GenCC):
  • epiphyseal dysplasia, multiple, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Illumina, G2P, Labcorp Genetics (formerly Invitae)
  • Stickler syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, ClinGen
  • Stickler syndrome, type 6
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • multiple epiphyseal dysplasia due to collagen 9 anomaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive Stickler syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 20-62826839-G-A is Benign according to our data. Variant chr20-62826839-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 258433.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0111 (1697/152246) while in subpopulation AFR AF = 0.0377 (1566/41530). AF 95% confidence interval is 0.0362. There are 43 homozygotes in GnomAd4. There are 805 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 43 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL9A3NM_001853.4 linkc.792+19G>A intron_variant Intron 15 of 31 ENST00000649368.1 NP_001844.3 Q14050

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL9A3ENST00000649368.1 linkc.792+19G>A intron_variant Intron 15 of 31 NM_001853.4 ENSP00000496793.1 Q14050
COL9A3ENST00000463487.2 linkn.500+19G>A intron_variant Intron 7 of 10 5
COL9A3ENST00000489045.5 linkn.*19G>A downstream_gene_variant 5

Frequencies

GnomAD3 genomes
AF:
0.0111
AC:
1689
AN:
152128
Hom.:
43
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0376
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00648
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.00861
GnomAD2 exomes
AF:
0.00293
AC:
724
AN:
247252
AF XY:
0.00222
show subpopulations
Gnomad AFR exome
AF:
0.0380
Gnomad AMR exome
AF:
0.00232
Gnomad ASJ exome
AF:
0.000100
Gnomad EAS exome
AF:
0.00115
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000718
Gnomad OTH exome
AF:
0.00149
GnomAD4 exome
AF:
0.00106
AC:
1553
AN:
1459958
Hom.:
23
Cov.:
32
AF XY:
0.000889
AC XY:
646
AN XY:
726296
show subpopulations
African (AFR)
AF:
0.0351
AC:
1176
AN:
33470
American (AMR)
AF:
0.00275
AC:
123
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26124
East Asian (EAS)
AF:
0.000680
AC:
27
AN:
39694
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86214
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51862
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000648
AC:
72
AN:
1111796
Other (OTH)
AF:
0.00227
AC:
137
AN:
60338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
89
179
268
358
447
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0111
AC:
1697
AN:
152246
Hom.:
43
Cov.:
33
AF XY:
0.0108
AC XY:
805
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.0377
AC:
1566
AN:
41530
American (AMR)
AF:
0.00647
AC:
99
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000191
AC:
13
AN:
67990
Other (OTH)
AF:
0.00852
AC:
18
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
91
181
272
362
453
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00476
Hom.:
1
Bravo
AF:
0.0131
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Intervertebral disc disorder;C1832998:Epiphyseal dysplasia, multiple, 3 Benign:1
May 11, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
6.0
DANN
Benign
0.35
PhyloP100
0.36
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115466848; hg19: chr20-61458191; API